List of Adare Pharma Solutions patents

Patents where

Current Assignee

Name

Adare Pharma Solutions

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10471071 Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis	Patent 10471071 was granted and assigned to Adare Pharma Solutions on November, 2019 by the United States Patent and Trademark Office.		Adare Pharma Solutions	United States Patent and Trademark Office	10471071	November 12, 2019
‌ US Patent 10105315 Methods of treating eosinophilic esophagitis	Patent 10105315 was granted and assigned to Adare Pharma Solutions on October, 2018 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10105315	October 23, 2018
‌ US Patent 9486407 Orally administered corticosteroid compositions	Patent 9486407 was granted and assigned to Adare Pharma Solutions on November, 2016 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	9486407	November 8, 2016
‌ US Patent 9339504 Orally disintegrating tablet compositions of lamotrigine	Patent 9339504 was granted and assigned to Adare Pharma Solutions on May, 2016 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	9339504	May 17, 2016
‌ US Patent 9387167 Orally administered corticosteroid compositions	Patent 9387167 was granted and assigned to Adare Pharma Solutions on July, 2016 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	9387167	July 12, 2016
‌ US Patent 9849084 Orally administered corticosteroid compositions	Patent 9849084 was granted and assigned to Adare Pharma Solutions on December, 2017 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	9849084	December 26, 2017
‌ US Patent 10632069 Orally administered corticosteroid compositions	Patent 10632069 was granted and assigned to Adare Pharma Solutions on April, 2020 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10632069	April 28, 2020
‌ US Patent 10952971 Taste-masked pharmaceutical compositions with gastrosoluble pore-formers	Patent 10952971 was granted and assigned to Adare Pharma Solutions on March, 2021 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10952971	March 23, 2021
‌ US Patent 9668979 Piperaquine microcapsules and compositions containing them	Patent 9668979 was granted and assigned to Adare Pharma Solutions on June, 2017 by the United States Patent and Trademark Office.		Adare Pharma Solutions	United States Patent and Trademark Office	9668979	June 6, 2017
‌ US Patent 9572781 Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics	Patent 9572781 was granted and assigned to Adare Pharma Solutions on February, 2017 by the United States Patent and Trademark Office.		Adare Pharma Solutions	United States Patent and Trademark Office	9572781	February 21, 2017
‌ US Patent 9358214 Timed, sustained release systems for propranolol	Patent 9358214 was granted and assigned to Adare Pharma Solutions on June, 2016 by the United States Patent and Trademark Office.		Adare Pharma Solutions	United States Patent and Trademark Office	9358214	June 7, 2016
‌ US Patent 9566249 Timed, pulsatile release systems	Patent 9566249 was granted and assigned to Adare Pharma Solutions on February, 2017 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	9566249	February 14, 2017
‌ US Patent 9375410 Modified release dosage forms of skeletal muscle relaxants	Patent 9375410 was granted and assigned to Adare Pharma Solutions on June, 2016 by the United States Patent and Trademark Office.		Adare Pharma Solutions	United States Patent and Trademark Office	9375410	June 28, 2016
‌ US Patent 9399025 Modified release dosage forms of skeletal muscle relaxants	Patent 9399025 was granted and assigned to Adare Pharma Solutions on July, 2016 by the United States Patent and Trademark Office.		Adare Pharma Solutions	United States Patent and Trademark Office	9399025	July 26, 2016
‌ US Patent 10864166 Drug delivery systems comprising solid solutions of weakly basic drugs	Patent 10864166 was granted and assigned to Adare Pharma Solutions on December, 2020 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10864166	December 15, 2020
‌ US Patent 10500161 Timed, pulsatile release systems	Patent 10500161 was granted and assigned to Adare Pharma Solutions on December, 2019 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10500161	December 10, 2019
‌ US Patent 9579293 Timed, pulsatile release systems	Patent 9579293 was granted and assigned to Adare Pharma Solutions on February, 2017 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	9579293	February 28, 2017
‌ US Patent 10045946 Timed, pulsatile release systems	Patent 10045946 was granted and assigned to Adare Pharma Solutions on August, 2018 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10045946	August 14, 2018
‌ US Patent 11026893 Taste masking drug formulations	Patent 11026893 was granted and assigned to Adare Pharma Solutions on June, 2021 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	11026893	June 8, 2021
‌ US Patent 10130580 Taste-masked pharmaceutical compositions	Patent 10130580 was granted and assigned to Adare Pharma Solutions on November, 2018 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10130580	November 20, 2018
‌ US Patent 10441554 Oral amphetamine composition	Patent 10441554 was granted and assigned to Adare Pharma Solutions on October, 2019 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10441554	October 15, 2019
‌ US Patent 9161919 Timed, pulsatile release systems	Patent 9161919 was granted and assigned to Adare Pharma Solutions on October, 2015 by the United States Patent and Trademark Office.		Adare Pharma Solutions	United States Patent and Trademark Office	9161919	October 20, 2015
‌ US Patent 10471017 Taste-masked pharmaceutical compositions with gastrosoluble pore-formers	Patent 10471017 was granted and assigned to Adare Pharma Solutions on November, 2019 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10471017	November 12, 2019
‌ US Patent 10568832 Taste-masked pharmaceutical compositions	Patent 10568832 was granted and assigned to Adare Pharma Solutions on February, 2020 by the United States Patent and Trademark Office.	Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10568832	February 25, 2020
‌ US Patent 10874612 Biodegradable polymer microsphere compositions for parenteral administration		Adare Pharma Solutions	Adare Pharma Solutions	United States Patent and Trademark Office	10874612	December 29, 2020

Results per page:

29 results

0 selected

29 results

0 selected